CEO Irish Jian Buys 46,000 Shares of Metagenomi Therapeutics at Zero-Cost RSU – Insider Confidence Sparks 161% Social‑Media Surge
CEO Irish Jian’s latest 46k‑share RSU purchase signals confidence in Metagenomi’s biotech pipeline and may boost investor sentiment, but stock volatility remains high.
4 minutes to read
